NuGene International Inc
Livento Group, Inc., through its subsidiaries, engages in the film and television production business in the United States. The company is also involved in the real estate finance and development; artificial intelligence; and machine learning technology businesses. It also provides Elisee, a software product that read market data and neurological network abilities to determine the path forward an… Read more
NuGene International Inc (NUGN) - Total Liabilities
Latest total liabilities as of September 2025: $2.59 Million USD
Based on the latest financial reports, NuGene International Inc (NUGN) has total liabilities worth $2.59 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
NuGene International Inc - Total Liabilities Trend (2013–2024)
This chart illustrates how NuGene International Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
NuGene International Inc Competitors by Total Liabilities
The table below lists competitors of NuGene International Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cartica Acquisition Corp Warrant
NASDAQ:CITEW
|
USA | $11.07 Million |
|
Premier Biomedical Inc
PINK:BIEI
|
USA | $2.56 Million |
|
Fbec Worldwide
PINK:FBEC
|
USA | $1.82 Million |
|
Colibri Resource Corporation
PINK:CRUCF
|
USA | $2.30 Million |
|
Cyon Exploration Ltd
PINK:CYNXF
|
USA | $1.61 Million |
|
PureWave Hydrogen Corp.
V:PWH
|
Canada | CA$181.53K |
|
Compuage Infocom Limited
NSE:COMPINFO
|
India | ₹8.44 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down NuGene International Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 20.99 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NuGene International Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NuGene International Inc (2013–2024)
The table below shows the annual total liabilities of NuGene International Inc from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $4.18 Million | +8.95% |
| 2023-12-31 | $3.84 Million | +18.16% |
| 2022-12-31 | $3.25 Million | +1154.58% |
| 2021-12-31 | $258.90K | +5078.00% |
| 2020-12-31 | $5.00K | -99.92% |
| 2016-12-31 | $6.06 Million | +380.90% |
| 2015-12-31 | $1.26 Million | +156.02% |
| 2014-12-31 | $492.56K | +39305.04% |
| 2013-12-31 | $1.25K | -- |